Penumbra (PEN) Shares Outstanding (2014 - 2026)
Penumbra (PEN) posted quarterly Shares Outstanding (Entity) of $39.4 million for Q2 2026, up 1.07% year-over-year from $39.0 million in Q2 2025, and little changed quarter-over-quarter from $39.3 million in Q1 2026.
Penumbra (PEN) Shares Outstanding (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Shares Outstanding (Entity) for 13 consecutive years, with $39.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 1.07% year-over-year to $39.4 million; the TTM figure through Jun 2026 stood at $39.4 million (up 1.07% YoY), while the FY2025 annual figure was $39.2 million, up 1.92% from the prior year.
- Shares Outstanding (Entity) held at $39.4 million in Q2 2026 per PEN's latest filing, from $39.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $39.4 million in Q2 2026 and bottomed at $37.7 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $38.6 million across 5 years, with a median of $38.6 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 3.58% — and 2024, when it declined 0.54%.
- Penumbra's Shares Outstanding (Entity) stood at $38.1 million in 2022, then increased by 1.51% to $38.7 million in 2023, then retreated by 0.49% to $38.5 million in 2024, then gained by 1.92% to $39.2 million in 2025, then advanced by 0.41% to $39.4 million in 2026.
- Business Quant data shows PEN's Shares Outstanding (Entity) at $39.4 million in Q2 2026, $39.3 million in Q1 2026, and $39.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 39.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.35 Mn |
| Mar 31, 2026 | 39.28 Mn |
| Dec 31, 2025 | 38.92 Mn |
| Sep 30, 2025 | 39.08 Mn |
| Jun 30, 2025 | 38.83 Mn |
| Mar 31, 2025 | 38.56 Mn |
| Dec 31, 2024 | 38.63 Mn |
| Sep 30, 2024 | 38.61 Mn |
| Jun 30, 2024 | 38.79 Mn |
| Mar 31, 2024 | 38.72 Mn |
| Dec 31, 2023 | 38.40 Mn |
| Sep 30, 2023 | 38.46 Mn |
| Jun 30, 2023 | 38.32 Mn |
| Mar 31, 2023 | 38.19 Mn |
| Dec 31, 2022 | 37.84 Mn |
| Sep 30, 2022 | 37.92 Mn |
| Jun 30, 2022 | 37.77 Mn |
| Mar 31, 2022 | 37.65 Mn |
| Dec 31, 2021 | 36.76 Mn |
| Sep 30, 2021 | 36.62 Mn |